More

    COVAXIN Subjected to 200 Quality Control Checks – Bharat Biotech

    There have been recent articles in social media and media outlets regarding the quality of COVAXIN®, In a statement issued today, Bharat Biotech set the record straight with the following statements.

    As of date all batches of COVAXIN® are manufactured and released only from our manufacturing facilities at Genome Valley Hyderabad, which are fully audited and approved by regulatory authorities, hence we wish to put to rest any concerns on the quality of COVAXIN®,   

    Every batch of COVAXIN® is subjected to more than 200 quality control tests at our facilities, followed by submission samples to Central Drugs Laboratory (CDL) Government of India, only based on approval/release by CDL, are batches released commercially,

    Since early June, manufacturing of COVAXIN® has commenced at our sites at Malur, Karnataka, and Ankleshwar, Gujarat, prior to which engineering batches were also executed to study equipment functionality. Products manufactured from these facilities will be available for supplies during September. This is based on our 120-day timeline for manufacturing, testing, release, regulatory approvals, and distribution,   

    Vaccine manufacturing, testing, and release at Bharat Biotech follow validated, stringent GMP processes which were established over 20 years, with several billion doses of vaccines supplied within India and globally,

    Since vaccines are administered to healthy individuals, safety is always our vital, primary criteria and we have an uncompromising policy on safety, and quality, whatsoever. This is evident from the excellent safety contours of COVAXIN® with an impressive supply of ~ 70 million doses to date. It is emblematic that Bharat Biotech has not sought Indemnity from the Government of India for any adverse events from COVAXIN®,  

    Fake news and false and misleading narratives result in unintended consequences of creating panic in our population, resulting in vaccine hesitancy

    The whole-virion Inactivated Vero Cell vaccines (COVAXIN® technology platform) are highly complex to manufacture as the critical ingredient is based on live viruses which require highly sophisticated, multiple level containment and purification methods. Such extensive, high standards of purification naturally lead to significant process losses and low yields resulting in a highly purified and safe vaccine,

    The SARS COV2 strains provided under material transfer agreements to Bharat Biotech are also readily available at the ICMR-NIV and is accessible to any organization that wishes to manufacture a similar COVID-19 vaccine, 

    Vaccinology, vaccine manufacturing, testing, and release is a complex multifactorial science involving inputs from more than 30 scientific and technological disciplines. This is evident from the fact that since the start of the pandemic only 2 vaccine companies have been able to supply COVID-19 vaccines to the Government of India, 

    Bharat biotech is the only company to develop a vaccine indigenously in India and manufacture it large scale. It has accomplished this in a matter of 15 months, with 10 publications and global recognition for India as an innovator and product developer. COVAXIN® is the only vaccine to have demonstrated efficacy against the delta variant in phase III human clinical trials,

    Fake news and false and misleading narratives result in unintended consequences of creating panic in our population, resulting in vaccine hesitancy, extending our country’s timelines to return to normalcy and restoration of livelihoods. We humbly request media organizations and influencers to use caution, restraint, detailed analysis in their reportage and their external communication, 

    Share

    Latest Updates

    Related Articles

    Now Go Karaoke with Apple Music Sing, Its New, Its Exciting

    Apple Music Sing has created excitement for karaoke enthusiasts. The Apple Music Sing, a...

    IND vs Bangladesh 2nd ODI Clash Today, Will India Capture its Lost Glory?

    Ind vs Bangladesh is a fight to watch today. The second One-Day International at...

    Its official, Divya Aggarwal is engaged to Apurva Padgaonkar

    Apurva Padgaonkar and Bigg Boss OTT winner Divya Aggarwal have made their relationship official....

    Brazil vs South Korea: Neymar dribbles his magic in Brazil’s 4-1 win

    Brazil vs South Korea was a spectacular knockout match to watch and the Brazilian...